期刊文献+

Interactions of chemical carcinogens and genetic variation in hepatocellular carcinoma 被引量:2

在线阅读 下载PDF
导出
摘要 In the etiology of hepatocellular carcinoma (HCC), in addition to hepatitis B virus and hepatitis C virus infections, chemical carcinogens also play important roles. For example, aflatoxin B 1 (AFB 1 ) epoxide reacts with guanine in DNA and can lead to genetic changes. In HCC, the tumor suppressor gene p53 codon 249 mutation is associated with AFB 1 exposure and mutations in the K -ras oncogene are related to vinyl chloride exposure. Numerous genetic alterations accumulate during the process of hepatocarcinogenesis. Chemical carcinogen DNA-adduct formation is the basis for these genetic changes and also a molecular marker which reflects exposure level and biological effects. Metabolism of chemical carcinogens, including their activation and detoxification, also plays a key role in chemical hepatocarcinogenesis. Cytochrome p450 enzymes, N -acetyltransferases and glutathione S -transferases are involved in activating and detoxifying chemical carcinogens. These enzymes are polymorphic and genetic variation influences biological response to chemical carcinogens. This genetic variation has been postulated to influence the variability in risk for HCC observed both within and across populations. Ongoing studies seek to fully understand the mechanisms by which genetic variation in response to chemical carcinogens impacts on HCC risk. In the etiology of hepatocellular carcinoma (HCC), in addition to hepatitis B virus and hepatitis C virus infections, chemical carcinogens also play important roles. For example, aflatoxin B1 (AFB1) epoxide reacts with guanine in DNA and can lead to genetic changes. In HCC, the tumor suppressor gene p53 codon 249 mutation is associated with AFB1 exposure and mutations in the K-ras oncogene are related to vinyl chloride exposure. Numerous genetic alterations accumulate during the process of hepatocarcinogenesis. Chemical carcinogen DNA-adduct formation is the basis for these genetic changes and also a molecular marker which reflects exposure level and biological effects. Metabolism of chemical carcinogens, including their activation and detoxification, also plays a key role in chemical hepatocarcinogenesis. Cytochrome p450 enzymes, N-acetyltransferases and glutathione S-transferases are involved in activating and detoxifying chemical carcinogens. These enzymes are polymorphic and genetic variation influences biological response to chemical carcinogens. This genetic variation has been postulated to influence the variability in risk for HCC observed both within and across populations. Ongoing studies seek to fully understand the mechanisms by which genetic variation in response to chemical carcinogens impacts on HCC risk.
作者 Yu-Jing Zhang
出处 《World Journal of Hepatology》 CAS 2010年第3期94-102,共9页 世界肝病学杂志(英文版)(电子版)
关键词 Hepatocellular carcinoma Chemical CARCINOGENS AFLATOXIN B 1 POLYCYCLIC aromatic hydrocarbons 4-aminobiphenyl HEPATITIS B VIRUS HEPATITIS C VIRUS Glutathione S -transferase Cytochrome p450 enzymes Genetic variation Hepatocellular carcinoma Chemical carcinogens Aflatoxin B1 Polycyclic aromatic hydrocarbons 4-aminobiphenyl Hepatitis B virus Hepatitis C virus Glutathione S-transferase Cytochrome p450 enzymes Genetic variation
  • 相关文献

参考文献116

  • 1Masahiro Munaka,Kiyotaka Kohshi,Toshihiro Kawamoto,Shin Takasawa,Naoki Nagata,Hideaki Itoh,Susumu Oda,Takahiko Katoh.Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and the risk of hepatocellular carcinoma[J]. Journal of Cancer Research and Clinical Oncology . 2003 (6)
  • 2M. Weihrauch,M. Benicke,G. Lehnert,C. Wittekind,M. Bader,R. Wrbitzky,A. Tannapfel.High prevalence of K-ras-2 mutations in hepatocellular carcinomas in workers exposed to vinyl chloride[J]. International Archives of Occupational and Environmental Health . 2001 (6)
  • 3Guengerich FP,,Johnson WW,Shimada T,Ueng YF,Yam- azaki H,Langouet S.Activation and detoxification of aflatoxin B1. Mutation Research . 1998
  • 4Goodman MT,Moriwaki H,Vaeth M,Akiba S,Hayabuchi H,Mabuchi K.Prospective cohort study of risk factors for primary liver cancer in Hiroshima and Nagasaki, Japan. Epidemiology . 1995
  • 5Phillips DH.Polycyclic aromatic hydrocarbons in the diet. Mutation Research . 1999
  • 6IARC Polynuclear Aromatic Compounds, Part 1. Chemical Environmental nd Experimental Data. IARC Monographs on the Evaluation ofthe Carcinogenic Risk of Chemicals to Humans . 1983
  • 7Kadlubar FF.DNA adducts of carcinogenic aromatic amines. DNA adducts identification and biological significance . 1994
  • 8Poirier MC,Fullerton NF,Smith BA,Beland FA.DNA adduct formation and tumorigenesis in mice during the chronic administration of 4-aminobiphenyl at multiple dose levels. Carcinogenesis . 1995
  • 9Wang LY,Chen CJ,Zhang YJ,Tsai WY,Lee PH,Feitelson MA,Lee CS,Santella RM.4-Aminobiphenyl DNA damage in liver tissue of hepatocellular carcinoma patients and controls. American Journal of Epidemiology . 1998
  • 10IARC.IARC Monographys on evaluation of carcinogenic risk to humans In Some Drinking Water Disinfectants and Contaminants, including Arsenic. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans . 2004

共引文献13

同被引文献308

  • 1Satarug, Soisungwan,Garrett, Scott H,Sens, Mary Ann,Sens, Donald A.Cadmium, Environmental Exposure, and Health Outcomes[J]. Environmental Health Perspectives . 2010 (2)
  • 2Virginia Hernandez–Gea,Sara Toffanin,Scott L. Friedman,Josep M. Llovet.Role of the Microenvironment in the Pathogenesis and Treatment of Hepatocellular Carcinoma[J].Gastroenterology.2013(3)
  • 3Giovanna Fattovich,Tommaso Stroffolini,Irene Zagni,Francesco Donato.Hepatocellular carcinoma in cirrhosis: Incidence and risk factors[J].Gastroenterology.2004(5)
  • 4Gaetano Bertino,Isidoro Di Carlo,Annalisa Ardiri,Giuseppe Stefano Calvagno,Shirin Demma,Giulia Malaguarnera,Nicoletta Bertino,Mariano Malaguarnera,Adriana Toro,Michele Malaguarnera.Systemic therapies in hepatocellular carcinoma: present and future[J].Future Oncol.2013(10)
  • 5Igor P. Pogribny,Ivan Rusyn.Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma[J].Cancer Letters.2012
  • 6Gaetano Bertino,Annalisa Ardiri,Michele Malaguarnera,Giulia Malaguarnera,Nicoletta Bertino,Giuseppe Stefano Calvagno.Hepatocellualar Carcinoma Serum Markers[J].Seminars in Oncology.2012(4)
  • 7Manal M. Hassan,Lu-Yu Hwang,Chiq J. Hatten,Mark Swaim,Donghui Li,James L. Abbruzzese,Palmer Beasley,Yehuda Z. Patt.Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus[J]. Hepatology . 2002 (5)
  • 8Gaetano Bertino,Shirin Demma,Annalisa Ardiri,Maria Proiti,Salvatore Gruttadauria,Adriana Toro,Giulia Malaguarnera,Nicoletta Bertino,Michele Malaguarnera,Mariano Malaguarnera,Isidoro Di Carlo,Jingmin Zhao.Hepatocellular Carcinoma: Novel Molecular Targets in Carcinogenesis for Future Therapies[J]. BioMed Research International . 2014
  • 9Véronique Bouvard,Robert Baan,Kurt Straif,Yann Grosse,Béatrice Secretan,Fatiha El Ghissassi,Lamia Benbrahim-Tallaa,Neela Guha,Crystal Freeman,Laurent Galichet,Vincent Cogliano.A review of human carcinogens—Part B: biological agents[J]. Lancet Oncology . 2009 (4)
  • 10John F. Reichard,Michael Schnekenburger,Alvaro Puga.Long term low-dose arsenic exposure induces loss of DNA methylation[J]. Biochemical and Biophysical Research Communications . 2006 (1)

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部